MedTrace Logo

Renal Artery Denervation in Chronic Heart Failure Study

NCT01639378 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2016-11-11

No results posted yet for this study

Summary

The REACH study, is a prospective, double-blinded, randomised, controlled study of the safety and effectiveness of renal denervation in subjects with chronic systolic heart failure. Bilateral denervation will be performed using the Symplicity Catheter - a percutaneous system that delivers radio frequency (RF) energy through the luminal surface of the renal artery.

Conditions

  • Chronic Systolic Heart Failure

Interventions

PROCEDURE

Renal Denervation

Symplicity Catheter System

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Darrel P Francis, BA, MD · Imperial College London

  • Justin E Davies, MBBS, PHD · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2017-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01639378 on ClinicalTrials.gov